{"id":421,"date":"2024-04-25T12:11:54","date_gmt":"2024-04-25T12:11:54","guid":{"rendered":"http:\/\/annualreport-2025.guerillainteractive.co.uk\/?page_id=421"},"modified":"2025-07-24T13:03:04","modified_gmt":"2025-07-24T13:03:04","slug":"produits-et-suivi-pharmaceutiques","status":"publish","type":"page","link":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/produits-et-suivi-pharmaceutiques\/","title":{"rendered":"Produits et suivi pharmaceutiques"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Qualit\u00e9 et utilisation des m\u00e9dicaments\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Produits et suivi pharmaceutiques<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Les travaux de l\u2019EDQM sur l\u2019utilisation optimale des m\u00e9dicaments font partie int\u00e9grante d\u2019efforts plus larges de protection et d\u2019am\u00e9lioration de la sant\u00e9 publique. En veillant non seulement \u00e0 la qualit\u00e9 et \u00e0 l\u2019innocuit\u00e9 des m\u00e9dicaments et des soins de sant\u00e9, mais aussi \u00e0 la s\u00e9curit\u00e9 de leur utilisation par les personnes trait\u00e9es, l\u2019EDQM contribue \u00e0 renforcer l\u2019efficacit\u00e9 des traitements, \u00e0 r\u00e9duire les risques pour la sant\u00e9 et \u00e0 am\u00e9liorer la qualit\u00e9 de vie des patient\u00b7es. Ces activit\u00e9s concourent \u00e0 am\u00e9liorer l\u2019acc\u00e8s \u00e0 des m\u00e9dicaments et soins de sant\u00e9 de qualit\u00e9 pour tout le monde.<\/p>

Ces efforts sont supervis\u00e9s par le Comit\u00e9 europ\u00e9en sur les produits et les soins pharmaceutiques (CD-P-PH), avec le soutien de ses trois organes subordonn\u00e9s\u00a0: le Comit\u00e9 d\u2019Experts sur les normes de qualit\u00e9 et de s\u00e9curit\u00e9 relatives aux pratiques et au suivi pharmaceutiques (CD-P-PH\/PC), le Comit\u00e9 d\u2019Experts sur la classification des m\u00e9dicaments en mati\u00e8re de leur d\u00e9livrance (CD-P-PH\/PHO) et le Comit\u00e9 d\u2019Experts sur la r\u00e9duction des risques de sant\u00e9 publique li\u00e9s \u00e0 la falsification de produits m\u00e9dicaux et aux infractions similaires (CD-P-PH\/CMED). Ensemble, ils couvrent les principaux aspects de l\u2019utilisation sans danger et efficace des m\u00e9dicaments, prot\u00e9geant ainsi la sant\u00e9 publique.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Activit\u00e9s<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Documents d\u2019orientation et recommandations<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Deux nouveaux documents d\u2019orientation sur l\u2019utilisation sans danger des compl\u00e9ments alimentaires \u00e0 base de plantes ont \u00e9t\u00e9 finalis\u00e9s en\u00a02024 \u2013 l\u2019un destin\u00e9 aux personnels de sant\u00e9, l\u2019autre aux consommateurs et consommatrices. Ils visent \u00e0 renforcer la s\u00e9curit\u00e9 des personnes utilisant ces produits et \u00e0 les informer \u00e0 ce sujet. Les versions finales approuv\u00e9es de ces textes seront publi\u00e9es en\u00a02025.<\/p>

Un autre document d\u2019orientation sur les bonnes pratiques en mati\u00e8re de tra\u00e7abilit\u00e9 des m\u00e9dicaments en milieu hospitalier a \u00e9galement \u00e9t\u00e9 finalis\u00e9. Y sont formul\u00e9es des recommandations visant \u00e0 aider les autorit\u00e9s et les parties int\u00e9ress\u00e9es \u00e0 veiller \u00e0 ce que les bons m\u00e9dicaments soient administr\u00e9s \u00e0 la bonne personne, et ce, selon la bonne voie d\u2019administration, \u00e0 la bonne dose et au bon moment. Ce document sera publi\u00e9 en\u00a02025 (apr\u00e8s adoption), puis les parties int\u00e9ress\u00e9es travailleront \u00e0 sa mise en \u0153uvre.<\/p>

Un nouveau projet a \u00e9t\u00e9 lanc\u00e9 en\u00a02024 pour \u00e9laborer un document d\u2019orientation sur les conseils \u00e0 donner aux personnes qui suivent un traitement contre le cancer. Cette initiative vise \u00e0 fournir aux prestataires de soins de sant\u00e9 des outils pour soutenir les malades du cancer pendant leur traitement. Une r\u00e9union de lancement avec des expert\u00b7es des \u00c9tats membres et des parties int\u00e9ress\u00e9es s\u2019est tenue fin\u00a02024, marquant le d\u00e9but du processus de r\u00e9daction de ce document important.<\/p>

Un projet de recommandation sur les bonnes pratiques en mati\u00e8re de distribution de m\u00e9dicaments \u00e0 distance et en ligne a \u00e9t\u00e9 finalis\u00e9 et soumis aux trois comit\u00e9s subordonn\u00e9s du CD-P-PH. Le texte sera pr\u00e9sent\u00e9 au CD-P-PH pour adoption en\u00a02025.<\/p>

Le CD-P-PH\/PHO a publi\u00e9 102\u00a0recommandations sur la classification des m\u00e9dicaments et leurs conditions de d\u00e9livrance (avec ou sans prescription). Le comit\u00e9 a \u00e9galement lanc\u00e9 une consultation des parties int\u00e9ress\u00e9es pour un document d\u2019orientation sur la classification des m\u00e9dicaments, expliquant le raisonnement recommand\u00e9 pour l\u2019\u00e9valuation. Ce document pourra \u00e9galement \u00eatre utilis\u00e9 par les Autorit\u00e9s nationales comp\u00e9tentes pour d\u00e9terminer si un m\u00e9dicament peut \u00eatre d\u00e9livr\u00e9 sans ordonnance.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Communication avec les partenaires et parties int\u00e9ress\u00e9es<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dans un souci d\u2019harmonisation des efforts visant \u00e0 promouvoir les soins centr\u00e9s sur la personne malade et le bon usage des m\u00e9dicaments en Europe, l\u2019EDQM maintient des relations avec ses organisations internationales partenaires, dont l\u2019Agence europ\u00e9enne des m\u00e9dicaments (EMA) et l\u2019agence des Responsables d\u2019agences du m\u00e9dicament (HMA), notamment le groupe de travail sur les m\u00e9dicaments non soumis \u00e0 ordonnance du CMDh, ainsi que l\u2019Organisation mondiale de la Sant\u00e9 (OMS) et des organisations professionnelles actives dans le domaine de la sant\u00e9 publique et dans le secteur pharmaceutique, comme la F\u00e9d\u00e9ration internationale pharmaceutique (FIP), la European Society of Clinical Pharmacy (ESCP), la Soci\u00e9t\u00e9 europ\u00e9enne de pharmacie oncologique (ESOP), la F\u00e9d\u00e9ration europ\u00e9enne des h\u00f4pitaux et des soins de sant\u00e9 (HOPE), le Groupement pharmaceutique de l\u2019Union europ\u00e9enne (GPUE) et l\u2019Association Europ\u00e9enne des Pharmaciens d\u2019H\u00f4pitaux (EAHP).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Publications<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t
Orientations sur la revue de m\u00e9dication<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

L\u2019EDQM a finalis\u00e9 et publi\u00e9 des orientations sur la revue de m\u00e9dication en octobre 2024. Ce document est t\u00e9l\u00e9chargeable (en anglais et en fran\u00e7ais) sur FreePub, la plateforme d\u2019acc\u00e8s aux publications gratuites de l\u2019EDQM. Il fournit des recommandations pratiques pour optimiser les soins des personnes prises en charge gr\u00e2ce \u00e0 des revues structur\u00e9es de la m\u00e9dication. Pour assurer une large diffusion et adoption des orientations, un plan de promotion a \u00e9t\u00e9 \u00e9tabli pour 2025, comprenant une strat\u00e9gie de communication globale et un webinaire destin\u00e9 aux personnels de sant\u00e9. Les dates et modalit\u00e9s d\u2019inscription seront publi\u00e9es sur le site web de l\u2019EDQM.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t
Orientations concernant la diffusion des livrables relatifs aux produits et au suivi pharmaceutiques<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Un document d\u2019orientation concernant la diffusion des livrables relatifs aux produits et au suivi pharmaceutiques (en anglais uniquement) a \u00e9t\u00e9 \u00e9labor\u00e9 par le CD-P-PH\/PC en vue de fournir un cadre g\u00e9n\u00e9ral et des principes directeurs pour la diffusion des livrables du CD-P-PH et de ses comit\u00e9s subordonn\u00e9s, conform\u00e9ment \u00e0 leurs mandats.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Base de donn\u00e9es Melclass<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

La base de donn\u00e9es Melclass (melclass.edqm.eu<\/a>, en anglais uniquement) a \u00e9t\u00e9 r\u00e9guli\u00e8rement mise \u00e0 jour en\u00a02024 sur la base des recommandations concernant la classification des m\u00e9dicaments formul\u00e9es par le CD-P-PH\/PHO \u00e0 destination des Autorit\u00e9s nationales de sant\u00e9, ainsi que d\u2019apr\u00e8s les donn\u00e9es de classification fournies par ces autorit\u00e9s, l\u2019objectif \u00e9tant de faire en sorte que Melclass soit une source unique d\u2019information pour les parties int\u00e9ress\u00e9es impliqu\u00e9es dans la classification des m\u00e9dicaments selon leurs conditions de d\u00e9livrance.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tPage pr\u00e9c\u00e9dente<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tPage suivante<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Quality & use of medicines Qualit\u00e9 et utilisation des m\u00e9dicaments Pharmaceuticals and pharmaceutical care The EDQM\u2019s work on the optimal use of medicines is an integral part of a larger effort to protect and improve public health. By ensuring not only the quality and safety of medicines and healthcare but also how they are used […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"ocean_front_end_style_editor":"no","ocean_post_layout":"","ocean_both_sidebars_style":"","ocean_both_sidebars_content_width":0,"ocean_both_sidebars_sidebars_width":0,"ocean_sidebar":"","ocean_second_sidebar":"","ocean_disable_margins":"enable","ocean_add_body_class":"","ocean_shortcode_before_top_bar":"","ocean_shortcode_after_top_bar":"","ocean_shortcode_before_header":"","ocean_shortcode_after_header":"","ocean_has_shortcode":"","ocean_shortcode_after_title":"","ocean_shortcode_before_footer_widgets":"","ocean_shortcode_after_footer_widgets":"","ocean_shortcode_before_footer_bottom":"","ocean_shortcode_after_footer_bottom":"","ocean_display_top_bar":"default","ocean_display_header":"default","ocean_header_style":"","ocean_center_header_left_menu":"","ocean_custom_header_template":"","ocean_custom_logo":0,"ocean_custom_retina_logo":0,"ocean_custom_logo_max_width":0,"ocean_custom_logo_tablet_max_width":0,"ocean_custom_logo_mobile_max_width":0,"ocean_custom_logo_max_height":0,"ocean_custom_logo_tablet_max_height":0,"ocean_custom_logo_mobile_max_height":0,"ocean_header_custom_menu":"","ocean_menu_typo_font_family":"","ocean_menu_typo_font_subset":"","ocean_menu_typo_font_size":0,"ocean_menu_typo_font_size_tablet":0,"ocean_menu_typo_font_size_mobile":0,"ocean_menu_typo_font_size_unit":"px","ocean_menu_typo_font_weight":"","ocean_menu_typo_font_weight_tablet":"","ocean_menu_typo_font_weight_mobile":"","ocean_menu_typo_transform":"","ocean_menu_typo_transform_tablet":"","ocean_menu_typo_transform_mobile":"","ocean_menu_typo_line_height":0,"ocean_menu_typo_line_height_tablet":0,"ocean_menu_typo_line_height_mobile":0,"ocean_menu_typo_line_height_unit":"","ocean_menu_typo_spacing":0,"ocean_menu_typo_spacing_tablet":0,"ocean_menu_typo_spacing_mobile":0,"ocean_menu_typo_spacing_unit":"","ocean_menu_link_color":"","ocean_menu_link_color_hover":"","ocean_menu_link_color_active":"","ocean_menu_link_background":"","ocean_menu_link_hover_background":"","ocean_menu_link_active_background":"","ocean_menu_social_links_bg":"","ocean_menu_social_hover_links_bg":"","ocean_menu_social_links_color":"","ocean_menu_social_hover_links_color":"","ocean_disable_title":"default","ocean_disable_heading":"default","ocean_post_title":"","ocean_post_subheading":"","ocean_post_title_style":"","ocean_post_title_background_color":"","ocean_post_title_background":0,"ocean_post_title_bg_image_position":"","ocean_post_title_bg_image_attachment":"","ocean_post_title_bg_image_repeat":"","ocean_post_title_bg_image_size":"","ocean_post_title_height":0,"ocean_post_title_bg_overlay":0.5,"ocean_post_title_bg_overlay_color":"","ocean_disable_breadcrumbs":"default","ocean_breadcrumbs_color":"","ocean_breadcrumbs_separator_color":"","ocean_breadcrumbs_links_color":"","ocean_breadcrumbs_links_hover_color":"","ocean_display_footer_widgets":"default","ocean_display_footer_bottom":"default","ocean_custom_footer_template":"","footnotes":""},"class_list":["post-421","page","type-page","status-publish","hentry","entry"],"yoast_head":"\nPharmaceuticals and pharmaceutical care | Quality & use of medicines - EDQM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/produits-et-suivi-pharmaceutiques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmaceuticals and pharmaceutical care | Quality & use of medicines - EDQM\" \/>\n<meta property=\"og:description\" content=\"Quality & use of medicines Qualit\u00e9 et utilisation des m\u00e9dicaments Pharmaceuticals and pharmaceutical care The EDQM\u2019s work on the optimal use of medicines is an integral part of a larger effort to protect and improve public health. By ensuring not only the quality and safety of medicines and healthcare but also how they are used […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/produits-et-suivi-pharmaceutiques\/\" \/>\n<meta property=\"og:site_name\" content=\"EDQM\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-24T13:03:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/annualreport-2025.guerillainteractive.co.uk\/wp-content\/uploads\/2025\/05\/Guidelines-on-medication-review-PUBSD-244-724x1024.png\" \/>\n\t<meta property=\"og:image:width\" content=\"724\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/pharmaceuticals-and-pharmaceutical-care\\\/\",\"url\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/pharmaceuticals-and-pharmaceutical-care\\\/\",\"name\":\"Pharmaceuticals and pharmaceutical care | Quality & use of medicines - EDQM\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/pharmaceuticals-and-pharmaceutical-care\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/pharmaceuticals-and-pharmaceutical-care\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Guidelines-on-medication-review-PUBSD-244-scaled.png\",\"datePublished\":\"2024-04-25T12:11:54+00:00\",\"dateModified\":\"2025-07-24T13:03:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/pharmaceuticals-and-pharmaceutical-care\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/pharmaceuticals-and-pharmaceutical-care\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/pharmaceuticals-and-pharmaceutical-care\\\/#primaryimage\",\"url\":\"http:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Guidelines-on-medication-review-PUBSD-244-scaled.png\",\"contentUrl\":\"http:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Guidelines-on-medication-review-PUBSD-244-scaled.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/pharmaceuticals-and-pharmaceutical-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmaceuticals and pharmaceutical care | Quality & use of medicines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/\",\"name\":\"EDQM\",\"description\":\"2023 Annual Report\",\"publisher\":{\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#organization\",\"name\":\"EDQM\",\"url\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/cropped-EDQM-Favicon.jpg\",\"contentUrl\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/cropped-EDQM-Favicon.jpg\",\"width\":512,\"height\":512,\"caption\":\"EDQM\"},\"image\":{\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmaceuticals and pharmaceutical care | Quality & use of medicines - EDQM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/produits-et-suivi-pharmaceutiques\/","og_locale":"fr_FR","og_type":"article","og_title":"Pharmaceuticals and pharmaceutical care | Quality & use of medicines - EDQM","og_description":"Quality & use of medicines Qualit\u00e9 et utilisation des m\u00e9dicaments Pharmaceuticals and pharmaceutical care The EDQM\u2019s work on the optimal use of medicines is an integral part of a larger effort to protect and improve public health. By ensuring not only the quality and safety of medicines and healthcare but also how they are used […]","og_url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/produits-et-suivi-pharmaceutiques\/","og_site_name":"EDQM","article_modified_time":"2025-07-24T13:03:04+00:00","og_image":[{"width":724,"height":1024,"url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/wp-content\/uploads\/2025\/05\/Guidelines-on-medication-review-PUBSD-244-724x1024.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/pharmaceuticals-and-pharmaceutical-care\/","url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/pharmaceuticals-and-pharmaceutical-care\/","name":"Pharmaceuticals and pharmaceutical care | Quality & use of medicines - EDQM","isPartOf":{"@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/pharmaceuticals-and-pharmaceutical-care\/#primaryimage"},"image":{"@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/pharmaceuticals-and-pharmaceutical-care\/#primaryimage"},"thumbnailUrl":"http:\/\/annualreport-2025.guerillainteractive.co.uk\/wp-content\/uploads\/2025\/05\/Guidelines-on-medication-review-PUBSD-244-scaled.png","datePublished":"2024-04-25T12:11:54+00:00","dateModified":"2025-07-24T13:03:04+00:00","breadcrumb":{"@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/pharmaceuticals-and-pharmaceutical-care\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/annualreport-2025.guerillainteractive.co.uk\/pharmaceuticals-and-pharmaceutical-care\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/pharmaceuticals-and-pharmaceutical-care\/#primaryimage","url":"http:\/\/annualreport-2025.guerillainteractive.co.uk\/wp-content\/uploads\/2025\/05\/Guidelines-on-medication-review-PUBSD-244-scaled.png","contentUrl":"http:\/\/annualreport-2025.guerillainteractive.co.uk\/wp-content\/uploads\/2025\/05\/Guidelines-on-medication-review-PUBSD-244-scaled.png"},{"@type":"BreadcrumbList","@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/pharmaceuticals-and-pharmaceutical-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/"},{"@type":"ListItem","position":2,"name":"Pharmaceuticals and pharmaceutical care | Quality & use of medicines"}]},{"@type":"WebSite","@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#website","url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/","name":"EDQM","description":"2023 Annual Report","publisher":{"@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#organization","name":"EDQM","url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#\/schema\/logo\/image\/","url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/wp-content\/uploads\/2024\/04\/cropped-EDQM-Favicon.jpg","contentUrl":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/wp-content\/uploads\/2024\/04\/cropped-EDQM-Favicon.jpg","width":512,"height":512,"caption":"EDQM"},"image":{"@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#\/schema\/logo\/image\/"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/pages\/421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/comments?post=421"}],"version-history":[{"count":59,"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/pages\/421\/revisions"}],"predecessor-version":[{"id":5012,"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/pages\/421\/revisions\/5012"}],"wp:attachment":[{"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/media?parent=421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}